ACTOPLUS MET vs AIMOVIG

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 21, 2026·How we rate

Possible drug interaction. ACTOPLUS MET and AIMOVIG are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	ACTOPLUS MET	AIMOVIG
Rating	New	72/100
Pharmacy pays	~$0.74 /30	—
Type	RX	RX
Active ingredient	METFORMIN HYDROCHLORIDE AND PIOGLITAZONE HYDROCHLORIDE	ERENUMAB-AOOE
Manufacturer	Takeda Pharms USA	Amgen Inc
Dosage forms	Tablet	Injectable, Solution
Drug class	—	—
Boxed warning	Boxed warning	None
Half-life	about 3 to 7 hours (parent drug)	—

actoplus met aimovig

Rating

New

72/100

Pharmacy pays

~$0.74 /30

—

Type

Active ingredient

METFORMIN HYDROCHLORIDE AND PIOGLITAZONE HYDROCHLORIDE

ERENUMAB-AOOE

Manufacturer

Takeda Pharms USA

Amgen Inc

Dosage forms

Tablet

Injectable, Solution

Drug class

—

Boxed warning

None

Half-life

about 3 to 7 hours (parent drug)

—

Frequently asked questions

What is the difference between Actoplus Met and Aimovig?

Actoplus Met contains Metformin Hydrochloride and Pioglitazone Hydrochloride, while Aimovig contains Erenumab-Aooe — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.